Health and Exercise Response in Children With Chronic and Auto-immune Pathologies

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Apr 11, 2019

Keywords

ClinConnect Summary

This clinical trial is studying how chronic diseases, like juvenile arthritis, diabetes, and cancer survivorship, affect children's physical fitness and muscle function. The researchers want to understand how these conditions and their treatments impact children's ability to exercise and how this can be used to improve their quality of life. By comparing children with chronic conditions to healthy peers, the study aims to find ways to recommend physical activities that can help reduce pain, fatigue, and inflammation, while also improving muscle strength and overall health.

To participate in this study, children aged 6 to 18 years old who have a chronic health issue that affects their muscles and metabolism may be eligible. Parents or guardians will need to provide consent for their child to take part. Participants can expect to undergo tests that measure their muscle strength and endurance, both during specific exercises and general activities. This study is a great opportunity for families looking to better understand how physical activity can benefit their child's health and well-being in the long run.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * for patients:
• • Aged between 6 and 18-year-old
• • Male or female
• • Presenting a chronic pathology / having a treatment which is known to alter muscle mass and function, metabolism and body composition
• • Included in the active list of the hospital centre of Clermont-Ferrand
• • Free and informed consent of the holders of parental authority and the patient
• * Affiliated with the social security system for control:
• • Aged between 6 and 18-year-old
• • Male or female
• • Free and informed consent of the holders of parental authority and the patient
• • Affiliated with the social security system
• Exclusion Criteria:
• * for patients:
• • Treatment by systemic corticoids (\>1 week in the 30 days before test)
• • Contraindication to sport practice
• * Active infection for control:
• • Contraindication to sport practice
• • Chronic pathology susceptible to alter muscle mass and function, metabolism and body composition
• • Treatment susceptible to alter metabolism
• • Active infection